Advertisement

Introduction

  • Günter Kampf
Chapter

Abstract

The global increase of antibiotic resistance has resulted in a new recognition of antisepsis and disinfection to limit the spread of multi- or pan-resistant pathogens. Some biocidal agents used for antisepsis or disinfection can, however, evoke tolerance or resistance to the biocidal itself, sometimes also to other biocidal agents or even antibiotics. Antiseptic stewardship aims to reduce any avoidable selection pressure caused by biocidal agents, e.g. by a careful product selection. Some antiseptic products contain two or more active ingredients, but one of them may not add substantially to the overall efficacy but may cause tolerance or resistance in some bacterial species. Other antiseptic products contain one active ingredient with a rather strong adaptive potential while other biocidal agents for the same type of application may cause less selection pressure. The Florence statement said: “Avoid chemicals except where they provide an evidence-based health benefit AND there is adequate evidence demonstrating they are safe. Where antimicrobials are necessary, use safer alternatives that are not persistent and pose no risk to humans or ecosystems”. Based on this guidance, a critical evaluation of 15 biocidal agents and the most common types of types of antiseptic products will be made.

References

  1. 1.
    Andersson DI, Hughes D (2012) Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resis Updat: Rev Comment Antimicro Anticancer Chemother 15(3):162–172.  https://doi.org/10.1016/j.drup.2012.03.005CrossRefGoogle Scholar
  2. 2.
    Chapman JS (2003) Biocide resistance mechanisms. Int Biodeter Biodegr 51(2):133–138.  https://doi.org/10.1016/S0964-8305(02)00097-5CrossRefGoogle Scholar
  3. 3.
    Cogan NG (2013) Concepts in disinfection of bacterial populations. Math Biosci 245(2):111–125.  https://doi.org/10.1016/j.mbs.2013.07.007CrossRefPubMedGoogle Scholar
  4. 4.
    Department of Health and Human Services; Food and Drug Administration (2016) Safety and effectiveness of consumer antiseptics. Topical Antimicro Drug Products Over-the-Counter Human Use. Fed Reg 81(172):61106–61130Google Scholar
  5. 5.
    Farkas A, Butiuc-Keul A, Ciataras D, Neamtu C, Craciunas C, Podar D, Dragan-Bularda M (2013) Microbiological contamination and resistance genes in biofilms occurring during the drinking water treatment process. Sci Total Environ 443:932–938.  https://doi.org/10.1016/j.scitotenv.2012.11.068CrossRefPubMedGoogle Scholar
  6. 6.
    Fernandes P, Ferreira BS, Cabral JM (2003) Solvent tolerance in bacteria: role of efflux pumps and cross-resistance with antibiotics. Int J Antimicrob Agents 22(3):211–216CrossRefPubMedGoogle Scholar
  7. 7.
    Fernandez L, Breidenstein EB, Hancock RE (2011) Creeping baselines and adaptive resistance to antibiotics. Drug Resis Updat: Rev Comment Antimicro Anticancer Chemother 14(1):1–21.  https://doi.org/10.1016/j.drup.2011.01.001CrossRefGoogle Scholar
  8. 8.
    Halden RU, Lindeman AE, Aiello AE, Andrews D, Arnold WA, Fair P, Fuoco RE, Geer LA, Johnson PI, Lohmann R, McNeill K, Sacks VP, Schettler T, Weber R, Zoeller RT, Blum A (2017) The florence statement on triclosan and triclocarban. Environ Health Perspect 125(6):064501.  https://doi.org/10.1289/ehp1788CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hernando-Amado S, Blanco P, Alcalde-Rico M, Corona F, Reales-Calderon JA, Sanchez MB, Martinez JL (2016) Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials. Drug Resis Updat: Rev Comment Antimicro Anticancer Chemother 28:13–27.  https://doi.org/10.1016/j.drup.2016.06.007CrossRefGoogle Scholar
  10. 10.
    Jutkina J, Marathe NP, Flach CF, Larsson DGJ (2017) Antibiotics and common antibacterial biocides stimulate horizontal transfer of resistance at low concentrations. Sci Total Environ 616–617:172–178.  https://doi.org/10.1016/j.scitotenv.2017.10.312CrossRefPubMedGoogle Scholar
  11. 11.
    Kampf G (2016) Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect 94(3):213–227.  https://doi.org/10.1016/j.jhin.2016.08.018
  12. 12.
    Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens (Basel, Switzerland) 2(2):288–356.  https://doi.org/10.3390/pathogens2020288
  13. 13.
    Lüneberg K, Prado B, Broszat M, Dalkmann P, Díaz D, Huebner J, Amelung W, López-Vidal Y, Siemens J, Grohmann E, Siebe C (2018) Water flow paths are hotspots for the dissemination of antibiotic resistance in soil. Chemosphere 193:1198–1206.  https://doi.org/10.1016/j.chemosphere.2017.11.143CrossRefPubMedGoogle Scholar
  14. 14.
    Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9(1):34–39CrossRefPubMedGoogle Scholar
  15. 15.
    Maillard J-Y (2005) Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems. Ther Clin Risk Manag 1(4):307–320PubMedPubMedCentralGoogle Scholar
  16. 16.
    McBain AJ, Gilbert P (2001) Biocide tolerance and the harbingers of doom. Int Biodeter Biodegr 47(1):55–61CrossRefGoogle Scholar
  17. 17.
    McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, resistance. Clin Microbiol Rev 12(1):147–179PubMedPubMedCentralGoogle Scholar
  18. 18.
    McNamara PJ, Levy SB (2016) Triclosan: an instructive tale. Antimicrob Agents Chemother 60(12):7015–7016.  https://doi.org/10.1128/aac.02105-16CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Miquel S, Lagrafeuille R, Souweine B, Forestier C (2016) Anti-biofilm activity as a health issue. Front Microbiol 7:592.  https://doi.org/10.3389/fmicb.2016.00592CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Oliveira WF, Silva PMS, Silva RCS, Silva GMM, Machado G, Coelho L, Correia MTS (2018) Staphylococcus aureus and Staphylococcus epidermidis infections on implants. J Hosp Infect 98(2):111–117.  https://doi.org/10.1016/j.jhin.2017.11.008CrossRefPubMedGoogle Scholar
  21. 21.
    Ortega Morente E, Fernandez-Fuentes MA, Grande Burgos MJ, Abriouel H, Perez Pulido R, Galvez A (2013) Biocide tolerance in bacteria. Int J Food Microbiol 162(1):13–25.  https://doi.org/10.1016/j.ijfoodmicro.2012.12.028CrossRefPubMedGoogle Scholar
  22. 22.
    Russell AD (2001) Mechanisms of bacterial insusceptibility to biocides. Am J Infect Control 29(4):259–261.  https://doi.org/10.1067/mic.2001.115671CrossRefPubMedGoogle Scholar
  23. 23.
    Russell AD (2004) Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J Hosp Infect 57(2):97–104.  https://doi.org/10.1016/j.jhin.2004.01.004CrossRefPubMedGoogle Scholar
  24. 24.
    Shi X, Zhu X (2009) Biofilm formation and food safety in food industries. Trends Food Sci Technol 20(9):407–413CrossRefGoogle Scholar
  25. 25.
    Venter H, Henningsen ML, Begg SL (2017) Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines. Essays Biochem 61(1):1–10.  https://doi.org/10.1042/ebc20160053CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Wales AD, Davies RH (2015) Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics (Basel, Switzerland) 4(4):567–604.  https://doi.org/10.3390/antibiotics4040567
  27. 27.
    Wang J, Foxman B, Mody L, Snitkin ES (2017) Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms. Proc Natl Acad Sci USA 114(39):10467–10472.  https://doi.org/10.1073/pnas.1710235114CrossRefPubMedGoogle Scholar
  28. 28.
    WHO (2015) Global action plan on antimicrobial resistance. WHO. http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Institute of Hygiene and Environmental MedicineUniversity of GreifswaldGreifswaldGermany

Personalised recommendations